One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Simultaneous blockade of more than one pathway is considered to be a promising approach to overcome the low efficacy and acquired resistance of cancer therapies. Thus, a novel series of c-Met/HDAC ...